“Re-educating” tumor-associated macrophages by targeting NF-κB
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The nuclear factor κB (NF-κB) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-κB in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive “alternative” phenotype that requires IκB kinase β–mediated NF-κB activation. When NF-κB signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a “classically” activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-κB signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to “re-educate” the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/741fab83e5184295af0f590a594611ed/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-1.jpg)
![Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/2ca0616e0f4f417d8bd81ac7dc101f6c/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Self-citationColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Cited by
Items 501–600 of 802
Laviv, Y., Wang, J., Anderson, M. P., & Kasper, E. M. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0910-4 · Cited by 24
Vlaeminck, Y. D., Lecocq, Q., Giron, P., Heirman, C., Geeraerts, X., Bolli, E., Movahedi, K., Massa, S., Schoonooghe, S., Thielemans, K., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.023 · Cited by 24
The miR-23a∼27a∼24-2 microRNA Cluster Promotes Inflammatory Polarization of Macrophages
Boucher, A. C., Klopfenstein, N., Hallas, W. M., Skibbe, J. R., Appert, A., Jang, S. H., Pulakanti, K., Rao, S., Dahl, K. D. C., & Dahl, R. E. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.1901277 · Cited by 24
Macrophages — Masters of Immune Activation, Suppression and Deviation
Foey, A. (2014) · InTech eBooks · doi:10.5772/57541 · Cited by 27
Angiogenesis: From molecular mechanisms to translational implications
Li, B., & Xiu, R. (2013) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-121647 · Cited by 28
“[45] T.”
BackgroundJin, J., Zhao, Q., Wei, Z., Chen, K., Su, Y., Hu, X., & Peng, X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01138-9 · Cited by 25
“Indeed, macrophages have been proved to have intrinsic tumoricidal activity, but they could rapidly adopt an alternative phenotype that leads to tumor immunosuppression [138].”
BackgroundZhou, K., Zhong, Y., Song, M., Sun, Y., Zhu, W., Cheng, J., Xu, Y., Zhang, Z., Wang, P., Tang, Z., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001182 · Cited by 25
Pan, D., & Lin, X. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000001 · Cited by 25
Polarization of macrophages: mechanisms, markers and factors of induction
Fedorov, A. A., Ermak, N. A., Gerashchenko, T. S., Топольницкий, Е. Б., Шефер, Н. А., Родионов, Е. О., & Stakheyeva, M. N. (2022) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2022-21-4-124-136 · Cited by 24
Knowledge landscape of tumor-associated macrophage research: A bibliometric and visual analysis
Zhou, F., Liu, Y., Liu, C., Wang, F., Peng, J., Xie, Y., & Zhou, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1078705 · Cited by 24
Lei, X., Chen, M., Li, X., Huang, M., Nie, Q., Ma, N., Chen, H., Xu, N., Ye, W., & Zhang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.016 · Cited by 22
Gutiérrez‐Seijo, A., García‐Martínez, E., Barrio‐Alonso, C., Pareja-Malagón, M., Acosta-Ocampo, A., Fernández‐Santos, M. E., Puig‐Kröger, A., Parra‐Blanco, V., Mercader, E., Márquez‐Rodas, I., et al. (2021) · Cancers · doi:10.3390/cancers13163943 · Cited by 22
“It is known that NF-κB activation drives M2 polarization of TAMs [33] and its inhibition re-educates TAMs towards an anti-tumoral phenotype [34].”
BackgroundWang, T., Dong, Y., Yao, L., Lü, F., Wen, C., Wan, Z., Fan, L., Li, Z., Bu, T., Wei, M., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.002 · Cited by 27
Lo, S. Z. Y., Steer, J. H., & Joyce, D. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.020 · Cited by 24
Zhang, Z., He, L., Hu, S., Wang, Y., Lai, Q., Yang, P. C., Yu, Q., Zhang, S., Xiong, F., Simsekyilmaz, S., et al. (2015) · Europe PMC (PubMed Central) · Cited by 22
Kono, Y., Kawakami, S., Higuchi, Y., Maruyama, K., Yamashita, F., & Hashida, M. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.880443 · Cited by 22
“Recent reports demonstrate that the inhibition of NF-kB activity can suppress the polarization of TAM to M2 phenotype [11,15,16].”
BackgroundTLR Agonists That Induce IFN-β Abrogate Resident Macrophage Suppression of T Cells
Hamilton, M. J., Antignano, F., von Rossum, A., Boucher, J., Bennewith, K. L., & Krystal, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002045 · Cited by 22
“Related to this, there is some evidence that Arg1 may be induced via the NF-kB pathway (35), which is activated by all TLR signaling pathways, although more rapidly via the MyD88-dependent pathway (16).”
BackgroundMacrophages in ovarian cancer and their interactions with monoclonal antibody therapies
Osborn, G., Stavraka, C., Adams, R., Sayasneh, A., Ghosh, S., Montes, A., Lacy, K. E., Kristeleit, R. S., Spicer, J. F., Josephs, D. H., et al. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab020 · Cited by 22
“M2-like denotes a population-level phenotype that is skewed towards immunosuppressive and pro-repair functions, but which also exhibits some M1 properties that confer inflammatory protumoural effects [51, 53].”
BackgroundToll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts
Ohm, I. K., Alfsnes, K., Olsen, M. B., Ranheim, T., Sandanger, Ø., Dahl, T. B., Aukrust, P., Finsen, A. V., Yndestad, A., & Vinge, L. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104398 · Cited by 21
The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis
Taghavie-Moghadam, P. L., Butcher, M. J., & Galkina, E. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12392 · Cited by 23
Nanoparticles for immunotherapy
Anfray, C., Mainini, F., & Andón, F. T. (2020) · Frontiers of nanoscience · doi:10.1016/b978-0-08-102828-5.00011-5 · Cited by 27
Proteases in Cancer: Significance for Invasion and Metastasis
Sloane, B. F., List, K., Fingleton, B., & Matrisian, L. M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0885-7_15 · Cited by 25
“Such thinking has led to attempts to specifically alter NFκB signaling in tumor-associated macrophages in vivo (Hagemann et al. 2008).”
BackgroundBacterial-mediated DNA delivery to tumour associated phagocytic cells
Byrne, W. L., Murphy, C., Cronin, M. A., Wirth, T., & Tangney, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.030 · Cited by 23
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
Moyes, K. W., Davis, A. D., Hoglund, V. J., Haberthur, K., Lieberman, N. A. P., Kreuser, S. A., Deutsch, G. H., Franco, S., Locke, D., Carleton, M. O., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1507668 · Cited by 23
Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells
Poupot, M., Fournié, J., & Poupot, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0508278 · Cited by 21
“For instance, Hagemann et al. [ 41 ] showed recently that the inhibition of NF-B signaling in TAMs promotes a direct tumoricidal activity through NO production and reverses their immunosuppressive phenotype by promoting NK cell-mediated antitumor immunity through a release of IL-12.”
BackgroundNaora, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00018 · Cited by 22
“Inhibition of NF-κB signaling in TAMs has been found to induce an M2-to-M1 switch and lead to regression of ovarian tumor xenografts (75).”
BackgroundTargeting Inflammatory Signaling in Prostate Cancer Castration Resistance
Zhong, S., Huang, C., Chen, Z., Chen, Z., & Luo, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215000 · Cited by 21
“The polarization of macrophages to an immunosuppressive “alternative” phenotype via interleukin (IL)-1R and MyD88 requires IKK-mediated NF-κB activation [54].”
BackgroundGuo, H., Liu, Y., Gu, J., Wang, Y., Liu, L., Zhang, P., & Li, Y. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1824-7 · Cited by 20
Pătraș, L., Sesărman, A., Licărete, E., Lupuţ, L., Alupei, M. C., Rákosy-Tican, E., & Banciu, M. (2016) · Oncology Letters · doi:10.3892/ol.2016.4708 · Cited by 20
“Furthermore, NF‐κB signaling has been described as the main mechanism for maintaining the pro-tumor phenotype of TAMs (33,34).”
BackgroundGraffeo, C. S., Perry, A., Raghunathan, A., Kroneman, T. N., Jentoft, M. E., Driscoll, C. L. W., Neff, B. A., Carlson, M. L., Jacob, J. T., Link, M. J., et al. (2018) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0038-1627474 · Cited by 20
Seif, M., Hoppstädter, J., Breinig, F., & Kiemer, A. K. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.008 · Cited by 21
Guo, N., Zhou, Y., Wang, T., Lin, M., Chen, J., Zhang, Z., Zhong, X., Lu, Y., Yang, Q., Xu, D., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19301 · Cited by 20
Nanocarrier-based immunotherapy in cancer management and research
Bhaskar, S., & Singh, M. S. (2014) · ImmunoTargets and Therapy · doi:10.2147/itt.s62471 · Cited by 24
Therapeutic strategies for targeting the ovarian tumor stroma
Ko, S. Y., & Naora, H. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i6.194 · Cited by 21
Kadowaki, T., Yasui, Y., Takahashi, Y., Kohchi, C., Soma, G., & Inagawa, H. (2009) · PubMed · Cited by 23
Aberrant methylation patterns in colorectal cancer: a meta-analysis
Durso, D. F., Bacalini, M. G., do Valle, Í. F., Pirazzini, C., Bonafè, M., Castellani, G., Faria, A. M. C., Franceschi, C., Garagnani, P., & Nardini, C. (2017) · Oncotarget · doi:10.18632/oncotarget.14590 · Cited by 24
Progress in Tumor‐Associated Macrophages: From Bench to Bedside
Wang, Y., Lin, Y., Qiao, S., Wang, J., & Wang, H. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800232 · Cited by 21
Sami, A., & Raza, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457491 · Cited by 20
The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications
Ramar, V., Guo, S., Wang, G., & Liu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167883 · Cited by 26
“Suppressed NF-κ B activity results in the M1 phenotype, characterized by anti-tumor cytotoxicity; hence, NF-κ B may serve as a viable target for modulating macrophage phenotype within the tumor microenvironment [109,110].”
François, A., Dirheimer, L., Chateau, A., Lassalle, H., Yakavets, I., & Bezdetnaya, L. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s427350 · Cited by 19
“6,14 Therefore, TAMs are anticipated to be promising targets for novel anti-tumor therapeutic strategies by inhibiting the recruitment of TAMs to the tumor, 6,14 re-educating TAMs from their M2-like pro-tumoral phenotype to an M1-like anti-tumoral phenotype 7,15 or by killing TAMs directly.”
BackgroundTumor reversion: a dream or a reality
Tripathi, A., Kashyap, A., Tripathi, G., Yadav, J., Bibban, R., Aggarwal, N., Thakur, K., Chhokar, A., Jadli, M., Sah, A. K., et al. (2021) · Biomarker Research · doi:10.1186/s40364-021-00280-1 · Cited by 21
“TAM-specific inactivation of IKKβ, which disrupts NF-κB signaling resulted in an M2-to-M1 switch, recruitment of natural killer cells, and subsequent tumor regression in an ovarian cancer model [65].”
BackgroundReichle, A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_2 · Cited by 18
“Vice versa, inconsistencies offer an operational range for systems-directed therapeutic approaches [5,17, 19 ,23,34,35].”
BackgroundThe Clinical Features, Prognostic Significance, and Immune Heterogeneity of CD37 in Diffuse Glioma
Yan, X., Zhou, Q., Zhu, H., Liu, W., Xu, H., Yin, W., Zhao, M., Jiang, X., & Ren, C. (2021) · iScience · doi:10.1016/j.isci.2021.103249 · Cited by 18
Asghari, A., Nourmohammadi, H., Majidiani, H., Shariatzadeh, S. A., Anvari, D., Shamsinia, S., Ghasemi, E., Shams, M., & Basati, G. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17090-5 · Cited by 23
Targeting circulating tumor cells to prevent metastases
Gostomczyk, K., Marsool, M. D. M., Tayyab, H., Pandey, A., Borowczak, J., Macome, F., Chacón, J. A., Dave, T., Maniewski, M., & Szylberg, Ł. (2023) · Human Cell · doi:10.1007/s13577-023-00992-6 · Cited by 20
“On the one hand, TAMs secrete vascular endothelial growth factor or fibroblast growth factor—and cytokines (i.e., IL-6, TNF-α, and TGF-β) to promote CTCs survival, proliferation, and migration [126, 130].”
BackgroundOpposing effects of bortezomib-induced nuclear factor- B inhibition on chemical lung carcinogenesis
Karabela, S. P., Psallidas, I., Sherrill, T. P., Kairi, C. A., Zaynagetdinov, R., Cheng, D. S., Vassiliou, S., McMahon, F., Gleaves, L. A., Han, W., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs024 · Cited by 18
Viral Oncolysis — Can Insights from Measles Be Transferred to Canine Distemper Virus?
Lapp, S., Pfankuche, V. M., Baumgärtner, W., & Puff, C. (2014) · Viruses · doi:10.3390/v6062340 · Cited by 21
A Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC
Li, W., Meng, X., Yuan, H., Xiao, W., & Zhang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.755706 · Cited by 18
“Both the NF-kappa B signaling pathway (Hagemann et al., 2008; Mann et al., 2017) and JAKSTAT signaling pathway (Jiménez-García et al.”
BackgroundKhan, A. N. H., Emmons, T. R., Magner, W. J., Alqassim, E., Singel, K. L., Ricciuti, J., Eng, K. H., Odunsi, K. O., Tomasi, T. B., Lee, K. P., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03156-x · Cited by 18
Wang, L., Talebian, F., Liu, J. ‐., Khattabi, M., Yu, L., & Bai, X. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02662.x · Cited by 18
Cruz‐Leal, Y., Laurindo, M. F. L., Osugui, L., Luzardo, M. D. C., López‐Requena, A., Alonso, M. E., Álvarez, C., Popi, A. F., Mariano, M., Pérez, R., et al. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.01.006 · Cited by 20
Macrophages and their interactions with oncolytic viruses
Jakeman, P. G., Hills, T. E., Fisher, K. D., & Seymour, L. W. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.06.007 · Cited by 21
CaCO3-Encapsulated Au Nanoparticles Modulate Macrophages toward M1-like Phenotype
Yang, S., Zhang, Y., Lü, S., Yang, L., Yu, S., & Yang, H. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01608 · Cited by 17
Qualls, J. E., & Murray, P. J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00010-3 · Cited by 19
Murray, J. L., Thompson, P. A., Yoo, S. Y., Do, K.-A., Pande, M., Zhou, R., Liu, Y., Şahin, A. A., Bondy, M. L., & Brewster, A. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2445-x · Cited by 17
“Moreover, it has recently been demonstrated that NFkB activation can maintain immunosuppressive function of type 2 tumor-associated macrophages (TAM) [28] which have been found to comprise up to 50 % of breast tumor mass [29].”
BackgroundKono, Y., Kawakami, S., Higuchi, Y., Maruyama, K., Yamashita, F., & Hashida, M. (2014) · Cancer Science · doi:10.1111/cas.12452 · Cited by 18
Wu, C.-Y., Yang, H., Monie, A., Ma, B., Tsai, H.-H., Wu, T. ‐., & Hung, C. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1013-7 · Cited by 17
“Thus, our data indicate that treatment with poly(I:C) and PEI induces high IL-12 and MHC class II expression in the CD11b? macrophages indicating the ‘‘classically’’ activated phenotype of macrophage activation (M1 phenotype) [9, 13 ].”
Immune and metabolic checkpoints blockade: Dual wielding against tumors
Kazemi, M. H., Najafi, A., Karami, J., Ghazizadeh, F., Yousefi, H., Falak, R., & Safari, E. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107461 · Cited by 17
Mishra, S., Kinoshita, C., Axtman, A. D., & Young, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.824956 · Cited by 17
“Additionally, CK2 is known to partially mediate the switch to a more pro-inflammatory state in mouse macrophages (Hagemann et al., 2008; Chen et al., 2017).”
BackgroundHaga, E., Endo, Y., Haruta, M., Koba, C., Matsumura, K., Takamatsu, K., Ikeda, T., Nishimura, Y., & Senju, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303473 · Cited by 17
Arrazuria, R., Ladero-Auñon, I., Molina, E., Fuertes, M., Juste, R. A., Fernández, M., Pérez, V. P., Garrido, J. M., & Elguezábal, N. (2020) · Veterinary Sciences · doi:10.3390/vetsci7010007 · Cited by 16
“Furthermore, experimental studies have shown that polarized macrophage phenotypes can be reversible both in vitro and in vivo [49,50].”
BackgroundWedekind, H., Walz, K., Buchbender, M., Rieckmann, T., Strasser, E. F., Grottker, F., Fietkau, R., Frey, B., Gaipl, U. S., & Rückert, M. (2021) · Strahlentherapie und Onkologie · doi:10.1007/s00066-021-01856-4 · Cited by 19
Wang, X., Li, X., Zhang, X., Zang, L., Yang, H., Zhao, W., Zhao, H., Li, Q., Xia, B., Yu, Y., et al. (2015) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2015.04.008 · Cited by 16
Lira, G. A., de Azevedo, F., Lins, I. G. S., Marques, I., Lira, G. A., Eich, C., & Júnior, R. D. A. (2024) · Cancers · doi:10.3390/cancers16142496 · Cited by 15
Hart, K. M., Usherwood, E. J., & Berwin, B. L. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.13 · Cited by 16
Macrophage Polarisation: A collaboration of Differentiation, Activation and Pre-Programming?
Foey, A. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000293 · Cited by 23
Gómez-Cambronero, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9753-x · Cited by 15
The effect of talc particles on phagocytes in co-culture with ovarian cancer cells
Mandarino, A., Gregory, D. J., McGuire, C. C., LeBlanc, B. W., Witt, H. A., Rivera, L. M., Godleski, J. J., & Fedulov, A. V. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108676 · Cited by 16
Lipinski, S., & Tiemann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073374 · Cited by 16
“For instance, in the early stages of carcinogenesis, M1 macrophages display antitumor activity [128] and the fine-tuning of NF-κB signaling was shown to balance the antitumor and protumor properties of macrophages [129,130].”
BackgroundLucas, T., Abraham, D., Untergasser, G., Zins, K., Hofer, E., Gunsilius, E., & Aharinejad, S. (2009) · Stem Cells · doi:10.1002/stem.145 · Cited by 15
Are Macrophages in Tumors Good Targets for Novel Therapeutic Approaches?
Alahari, S. V., Dong, S., & Alahari, S. K. (2014) · Molecules and Cells · doi:10.14348/molcells.2015.2298 · Cited by 16
“In contrast, some reports indicate that targeted NF- B activation can induce apoptosis of hepatocytes while decreasing tumor size, suggesting multiple roles of NF- B (Greten et al., 2004; Hagemann et al., 2008; Luedde et al., 2007; Maeda et al., 2005; Naugler et al., 2007; Swain and Arezzo, 2008).”
Honda, T., Inagawa, H., & Yamamoto, I. (2011) · PubMed · Cited by 16
Sridaran, D., Ramamoorthi, G., Rasool, M., & Premkumar, K. (2016) · Tumor Biology · doi:10.1007/s13277-016-5224-6 · Cited by 14
Musick, M., & Yu, X. (2022) · Immunologic Research · doi:10.1007/s12026-022-09277-w · Cited by 14
“Furthermore, suppression of STAT1 in TAMs prevented TAM-mediated cytotoxicity against ID8 tumor cells [76].”
BackgroundChen, H., & Chen, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.883583 · Cited by 16
“Therefore, c-MYC and NFκB signaling may be potential targets to “re-educate” the M1 macrophage phenotype, indicating a novel therapeutic approach in the era of specific target cell therapy (Hagemann et al., 2008).”
BackgroundNEMO syndrome (incontinentia pigmenti) and systemic lupus erythematosus: A new disease association
Gb, P., Attini, R., Vigotti, F. N., Naretto, C., Fassio, F., Randone, O., Restagno, G., Todros, T., & Roccatello, D. (2012) · Lupus · doi:10.1177/0961203311433140 · Cited by 14
The duality of macrophage function in chronic lymphocytic leukaemia
Chen, Y.-C. E., Mapp, S., Blumenthal, A., Burgess, M. L., Mazzieri, R., Mattarollo, S. R., Mollee, P. N., Gill, D. S., & Saunders, N. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.006 · Cited by 16
Extracellular Matrix Remodeling in Intestinal Homeostasis and Disease
Lee, S.-E., Massie, I., Meran, L., & Li, V. S. W. (2018) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2018.01.001 · Cited by 16
Polverini, P. J., Nör, F., & Nor, J. E. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2022.1095842 · Cited by 15
Effect of acute inflammatory reaction induced by biopsy on tumor microenvironment
Chen, Y., Liu, H., & Sun, Y. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05704-7 · Cited by 13
“Changes in the tumor microenvironment after biopsy also include the upregulation of many vital inflammatory cytokines and mediators, including recombinant S100 calcium-binding protein A8 (S100A8), CXCL1, CXCL2, IL-1β, TNF-α, and COX2, which activate an inflammatory signaling cascade (including MyD88 and the transcript…”
BackgroundNfkb1 Inhibits LPS-Induced IFN-β and IL-12 p40 Production in Macrophages by Distinct Mechanisms
Zhao, X., Ross, E. J., Wang, Y., & Horwitz, B. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032811 · Cited by 13
Morishita, A., Gerber, A., Ch, G., Zelonina, T., Chada, K. K., & D'Armiento, J. M. (2018) · PubMed · Cited by 13
Tumor‐associated macrophages as treatment targets in glioma
Peng, Y., Chen, F., Li, S., Liu, X., Wang, C., Yu, C., & Li, W. (2020) · Brain Science Advances · doi:10.26599/bsa.2020.9050015 · Cited by 13
“Disruption of NF‐κB can also switch the M2 phenotype to M1 macrophages, resulting in tumor regression in the ovarian tumor model [90, 91].”
BackgroundChen, T., Yang, C., Dou, R., & Xiong, B. (2021) · Cancer Medicine · doi:10.1002/cam4.4180 · Cited by 13
Kadowaki, T., Inagawa, H., Kohchi, C., Hirashima, M., & Soma, G. (2011) · PubMed · Cited by 15
A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
Motais, B., Charvátová, S., Hrdinka, M., Šimíček, M., Jelínek, T., Ševčíková, T., Kořístek, Z., Hájek, R., & Bagó, J. R. (2020) · Cancers · doi:10.3390/cancers12051333 · Cited by 13
Bustamante-Marin, X. M., Merlino, J. L., Devericks, E. N., Carson, M. S., Hursting, S. D., & Stewart, D. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632284 · Cited by 12
“Obesity, Breast Cancer, and Immunosuppression Breast tumors are usually infiltrated by multiple immune cell populations, most notably macrophages, referred to as tumorassociated macrophages (TAMs), as well as neutrophils and T-cells, that can reduce treatment efficacy through immunosuppressive mechanisms (76, 97).”
BackgroundLin, T., Peng, W., Mai, P., Zhang, E., & Peng, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.626966 · Cited by 12
IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP
Karagiannis, S. N., Nestle, F. O., & Gould, H. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-451-7_8 · Cited by 13
Taniguchi, H., Shimada, Y., Sawachi, K., Hirota, K., Inagawa, H., Kohchi, C., Soma, G., Makino, K., & Terada, H. (2010) · PubMed · Cited by 16
Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma Microenvironment
Hannan, C. J., Lewis, D. G., O’Leary, C., Donofrio, C. A., Evans, D. G., Stapleton, E. J., Freeman, S. R. M., Lloyd, S., Rutherford, S. A., Hammerbeck-Ward, C. L., et al. (2020) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0040-1716688 · Cited by 13
Wang, X., Cui-min, J., Wan, H., Wu, J., Quan, W., Bals, R., Wu, K., & Li, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052117 · Cited by 12
Wu, H., Tao, A., Martin, J. D., Quader, S., Liu, X., Takahashi, K., Hespel, L., Miura, Y., Hayakawa, Y., Irimura, T., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.031 · Cited by 13
Andersen, M., Andersen, N., Lauridsen, K. L., Etzerodt, A., Sørensen, B., Abildgaard, N., Plesner, T., Hokland, M., & Møller, H. (2021) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-021-02952-1 · Cited by 13
Rahman, M. M., Talukder, A., Rahi, M. S., Das, P. K., Grice, I. D., Ulett, G. C., & Wei, M. Q. (2025) · Journal of Immunology Research · doi:10.1155/jimr/2289241 · Cited by 12
“Pro-in fl ammatory cytokines such as IL-1, IL-6, IL-12, and TNF-α have the potential to activate bacterial antigen-speci fi c adaptive responses, which may enhance tumor antigen recognition and response by tumor-speci fi c type 1 helper (Th1) and cytotoxic T cells [30, 31].”
Li, L., Wang, J., Huang, L., Chen, Y., & Chen, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649366 · Cited by 12
KCND2 : A prognostic biomarker and regulator of immune function in gastric cancer
Zhou, H., Su, D., Chen, Y., Zhang, Y., & Huang, P. C. (2023) · Cancer Medicine · doi:10.1002/cam4.6236 · Cited by 14
Li, Y., Wan, J., Wang, F., Guo, J., & Wang, C. (2019) · Biomaterials Science · doi:10.1039/c8bm01371c · Cited by 11
Honda, T., Yamamoto, I., & Inagawa, H. (2013) · PubMed · Cited by 14
Smith, H., Forman, R. A., Mair, I., & Else, K. J. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1505498 · Cited by 11
Metadata
- Authors
- Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R.
- Affiliations
- Queen Mary University of London (GB)
- 1Centre for Cancer and Inflammation
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-05-19
- Volume
- 205
- Issue
- 6
- Pages
- 1261-1268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2413024
- OpenAlex
- W2105724560
- Cited by
- 792
- References
- 25
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 32 · 2023: 28 · 2022: 42 · 2021: 41 · 2020: 45 · 2019: 31 · 2018: 50 · 2017: 49 · 2016: 49 · 2015: 46 · 2014: 73 · 2013: 64 · 2012: 41
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- tumor-associated macrophages, NF-κB signaling, macrophage polarization, alternative macrophage activation, IκB kinase β, MyD88, interleukin-1 receptor, IL-12, NK cell recruitment, tumor immunosuppression, tumor microenvironment, antitumor immunity, tumor regression
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Neoplasms, Phenotype, Signal Transduction, NF-kappa B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.